Picture of Cryo-Cell International logo

CCEL Cryo-Cell International News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSuper Stock

Brief: Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results

Oct 12 (Reuters) - Cryo-Cell International Inc  CCEL.A :
    * CORD BLOOD BANKING LEADER CRYO-CELL REPORTS FISCAL THIRD
QUARTER
2023 FINANCIAL RESULTS
    * CRYO-CELL INTERNATIONAL INC - CURRENTLY FUNDING COMPLETION
OF A
PHASE 2 AUTISM TRIAL AND EXPECT TO BEGIN A PHASE 3 CP TRIAL IN
FIRST HALF OF 2024
    * CRYO-CELL INTERNATIONAL INC - REPORTED NET INCOME FOR
THREE
MONTHS ENDED AUGUST 31, 2023 OF $681,000, OR $0.08 PER BASIC
SHARE AND DILUTED SHARE

Source text for Eikon:  ID:nBw60XSQYa 
Further company coverage:  CCEL.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cryo-Cell International

See all news